The US Food and Drug Administration on Thursday approved Gilead's antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and only drug approved for the disease in the US. Remdesivir was given to President Donald Trump this month when he was diagnosed with COVID-19. It was originally developed as a treatment for Ebola and Hepatitis C.